Gimbel, MD JS, Rauck, MD RL, Bass, PharmD A, Wilson, PharmD J, Pixton, MS G, Malhotra, PhD B, Wilson PhD G, Wolfram, MD G. Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone. J of Opioid Management [Internet]. 2019 Sep. 1 [cited 2024 Nov. 24];15(5):417-2. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/2665